Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Weekly Azathioprine Pulse therapy is more effective than Betamethasone Oral Mini-Pulse for hair regrowth in moderate to severe Alopecia Areata.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Baricitinib is effective for severe alopecia areata but has some side effects.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

The document doesn't say if the treatment for hair loss worked.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Baricitinib is effective and safe for treating severe alopecia areata.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.